Collagen biosynthesis method based on induced pluripotent stem cell technology

Through reprogramming and differentiation from donor cells based on inducible pluripotent stem cell technology, immune rejection and ethical disputes in collagen biosynthesis are solved, and efficient and personalized collagen synthesis and purification are achieved to ensure the biological activity of the product and Mechanical properties.

CN118910194AInactive Publication Date: 2024-11-08BEIJING SAIWEISEN INT BIOTECHNOLOGY CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410980887.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing collagen biosynthesis methods have risks of immune rejection and ethical controversy, and the efficiency of fibroblast synthesis is low.

Method used

Using induction pluripotent stem cell technology, the culture conditions are optimized to improve the synthesis efficiency and quality of collagen, ensuring genetic stability and multiplication by extracting somatic cells from donor cells, reprogramming into iPSCs, and through directed differentiation and gene regulation. Energy, high-purity collagen is obtained using a variety of extraction and purification techniques.

Benefits of technology

It has achieved the avoidance of immune rejection, reduced ethical disputes, improved the efficiency and quality of collagen synthesis, and provided personalized medical solutions to ensure that the biological activity and mechanical properties of synthetic collagen meet natural standards.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910194A_ABST
    Figure CN118910194A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of protoprotein biosynthesis, and particularly relates to a collagen biosynthesis method based on an induced pluripotent stem cell technology, and the collagen biosynthesis method specifically comprises the following steps: step 1, cell reprogramming: extracting somatic cells including fibroblasts and blood cells from the skin or blood of a donor, reprogramming factors are introduced into somatic cells by using a viral vector or a non-viral method, wherein the viral vector is a retrovirus or an adeno-associated virus. The method can utilize donor cells to synthesize collagen, avoids immunological rejection, realizes personalized medical treatment, reduces ethical dispute, optimizes culture and gene regulation to improve synthesis efficiency and quality, ensures genetic stability and pluripotency through strict quality control, can test and evaluate biological activity and mechanical properties, ensures high purity through multiple extraction and purification technologies, and is suitable for industrial production. Quality detection ensures that natural standards are met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of collagen biosynthesis, and in particular relates to a collagen biosynthesis method based on induced pluripotent stem cell technology. Background Art

[0002] Collagen is an important structural protein that is widely present in the connective tissues of the human body, including skin, bones, tendons and ligaments, accounting for about 30% of the total protein in the human body. Its functions include maintaining skin elasticity and smoothness, promoting wound healing, supporting bone health, enhancing joint health and improving muscle mass. Sources include animal foods such as meat, fish and poultry, especially parts rich in connective tissue, bone broth and broth, and eggshell membranes. It can also be supplemented through collagen supplements on the market. As we age, the synthesis rate of collagen in the human body slows down, leading to problems such as sagging skin, increased wrinkles and joint pain. Therefore, proper supplementation of collagen and maintaining a healthy lifestyle and eating habits can help delay these signs of aging.

[0003] The collagen synthesized by the existing collagen biosynthesis method is prone to immune rejection when used. The use of embryonic stem cells to synthesize collagen involves the use of embryos, which is ethically controversial. The collagen synthesis efficiency of fibroblasts is low. Therefore, we propose a collagen biosynthesis method based on induced pluripotent stem cell technology to solve the above problems. Summary of the invention

[0004] The purpose of the present invention is to provide a collagen biosynthesis method based on induced pluripotent stem cell technology, which can use donor cells to synthesize collagen, avoid immune rejection, realize personalized medicine, reduce ethical disputes, optimize culture and gene regulation to improve synthesis efficiency and quality, strictly control quality to ensure genetic stability and pluripotency, test and evaluate biological activity and mechanical properties, use a variety of extraction and purification technologies to ensure high purity, and ensure that quality inspections meet natural standards.

[0005] The technical solution adopted by the present invention is as follows:

[0006] A method for collagen biosynthesis based on induced pluripotent stem cell technology, the method comprising the following steps:

[0007] Step 1. Cell reprogramming: Somatic cells, including fibroblasts and blood cells, are extracted from the skin or blood of the donor, and reprogramming factors are introduced into the somatic cells using viral vectors or non-viral methods. The viral vectors are retroviruses or adeno-associated viruses, and the reprogramming factors include Oct4, Sox2, Klf4, and c-Myc. Under appropriate culture medium and conditions, the somatic cells are reprogrammed into iPSCs, and the iPSCs form characteristic cell colonies;

[0008] Step 2. iPSCs culture and expansion: Use a specific culture medium containing KOSR and bFGF to maintain the growth and pluripotency of iPSCs, use feeder-free culture medium or use culture plates coated with extracellular matrix proteins to regularly subculture iPSCs;

[0009] Step 3. Cell identification and quality control: Use immunofluorescence, flow cytometry or qPCR to detect the pluripotency markers of iPSCs, confirm the genetic stability of iPSCs through karyotype analysis and whole genome sequencing, and evaluate the pluripotency of iPSCs through in vitro differentiation experiments or in vivo tumor formation experiments;

[0010] Step 4. Directed differentiation: Use specific differentiation medium and growth factors to induce iPSCs to differentiate into fibroblasts or other collagen-synthesizing cell types. Optimize differentiation conditions by adjusting medium composition, cell density, culture temperature, and oxygen concentration. Use immunofluorescence and qPCR to detect fibroblast differentiation markers.

[0011] Step 5. Collagen synthesis and secretion: adjust the culture medium composition, amino acids, vitamin C, oxygen concentration and mechanical stress, regulate the expression of genes related to collagen synthesis through gene editing technology or small molecule compounds, collect culture medium samples regularly, and use ELISA or Western Blot to detect collagen secretion;

[0012] Step 6. Functional testing and optimization: Evaluate the biological functions of differentiated fibroblasts, including cell proliferation, migration, and collagen fiber formation ability. Use CRISPR / Cas9 technology to perform targeted editing of genes related to collagen synthesis. Use tensile tests and shear tests to evaluate the mechanical properties of synthesized collagen fibers.

[0013] Step 7. Extraction and purification of collagen: Collect secreted collagen from the culture medium, extract collagen by acid dissolution, salting out or enzymatic hydrolysis, purify collagen by centrifugation, dialysis, gel filtration chromatography, ion exchange chromatography, remove impurities, and detect the purity and molecular weight of purified collagen by SDS-PAGE, electrophoresis, and mass spectrometry;

[0014] Step 8. Quality inspection: Use infrared spectroscopy and circular dichroism to analyze the secondary structure of collagen, determine the amino acid composition of collagen, confirm the consistency of its amino acid sequence with natural collagen, and evaluate the effect of collagen on cell adhesion, proliferation and differentiation through cell culture experiments.

[0015] In a preferred embodiment, the cell reprogramming further comprises using trypsin or collagenase to digest a skin sample to separate fibroblasts, or using density gradient centrifugation to separate monocytes from a blood sample, inoculating the separated cells in a culture dish, culturing them using a culture medium containing growth factors, and reprogramming the cells after they proliferate to a suitable density, wherein the reprogramming factors include Oct4, Sox2, Klf4, and c-Myc, and co-incubating the reprogramming factor vector with the somatic cells, and the method comprises viral infection, plasmid electroporation, or liposome transfection, and inoculating the somatic cells introduced with the reprogramming factors in a culture dish containing a feeder layer, and using KOSR culture medium for initial culture.

[0016] In a preferred embodiment, the iPSCs culture and expansion further comprises using a feeder-free culture medium, coating a culture plate with extracellular matrix proteins to provide a surface suitable for iPSCs attachment and growth, diluting the matrix proteins before use and evenly coating the culture plate surface, incubating at room temperature for 30 minutes, inoculating the iPSCs suspension onto the pretreated feeder-free culture plate, culturing using a feeder-free culture medium, gently digesting the cell colonies using Dispase enzymes and Accutase enzymes to disperse them into single cell suspensions or small colonies, transferring the digested cells to fresh culture plates by centrifugation and resuspension. In the culture medium, inoculate the cell suspension onto a new feeder-free culture plate at an appropriate dilution ratio, change the culture medium regularly, remove waste and metabolites, add fresh nutrients, control the temperature, humidity and CO2 concentration of the culture environment to ensure that it is stable at 37°C, 95% relative humidity and 5% CO2, observe cell growth every day, record cell morphology and density, avoid excessive cell fusion or differentiation, regularly detect iPSCs pluripotency markers, Oct4, Sox2, Nanog expression levels, regularly perform karyotype analysis and whole genome sequencing, and regularly detect microbial contamination in the culture medium.

[0017] In a preferred embodiment, the cell identification and quality control also includes collecting iPSCs from a culture dish, fixing and permeabilizing the cells, fixing the cells with a 4% paraformaldehyde solution for 10-15 minutes, then washing with PBS, treating with 0.1% Triton X-100 at room temperature for 5-10 minutes to permeabilize the cell membrane, blocking with 5% BSA or 10% normal goat serum at room temperature for 1 hour, diluting the primary antibody against pluripotency markers according to the recommended concentration, adding it to the blocked sample, incubating at 4°C overnight, washing with PBS, adding a secondary antibody with a fluorescent label, incubating at room temperature for 1 hour, protecting from light, observing the staining results with a fluorescence microscope, confirming the expression of pluripotency markers, digesting iPSCs into a single cell suspension, adjusting the cell concentration, mixing the cells with the fluorescently labeled primary antibody, incubating at 4°C for 30 minutes, washing the cells with PBS to remove unbound antibodies, detecting the fluorescence intensity of the pluripotency markers using a flow cytometer, and analyzing the pluripotency of the cells.

[0018] In a preferred embodiment, the directed differentiation also includes determining the target differentiation direction of iPSCs according to experimental requirements, selecting a basal culture medium suitable for the target cell type, adding specific growth factors and small molecules according to the target cell type, systematically adjusting the concentration and combination of each component in the culture medium, performing gradient tests on the concentration of each growth factor and small molecule, and performing combination experiments of different growth factors and small molecules to find synergistic effects. During the differentiation process, timely subculturing according to cell growth conditions, regularly collecting cell samples during the differentiation process for marker detection, fixing cells with 4% paraformaldehyde, permeabilizing with 0.1% Triton X-100, incubating with primary and secondary antibodies using specific fibroblast marker antibodies, observing the expression of fibroblast markers, evaluating the differentiation effect, calculating the differentiation efficiency, evaluating the proportion of cells successfully differentiated under specific conditions, evaluating the functional properties of differentiated cells through collagen synthesis detection, migration and proliferation experiments, and culturing differentiated cells for a long time to observe their stability and functional retention.

[0019] In a preferred embodiment, the collagen synthesis and secretion also includes simulating hypoxic conditions by adjusting the oxygen concentration of the incubator to promote collagen synthesis, simulating the mechanical stress to which cells are subjected in vivo, and applying mechanical stress by using a bioreactor or a specially designed culture medium rack to promote collagen synthesis and secretion by fibroblasts.

[0020] In a preferred embodiment, the functional testing and optimization also includes using CRISPR / Cas9 technology to precisely regulate the expression of genes related to collagen synthesis, designing single guide RNA for target genes, and constructing CRISPR / Cas9 vectors, transfecting CRISPR / Cas9 vectors into fibroblasts, improving transfection efficiency by nucleic acid electroporation or liposome transfection, screening successfully edited cell lines, and using qPCR and Western blot to detect the expression of genes related to collagen synthesis. Blot was used to verify the expression of target genes, and small molecule compounds that can regulate the expression of genes related to collagen synthesis were screened. The synthesis and secretion of collagen were increased by adding these small molecule compounds. During the cell culture process, culture medium samples were collected regularly for collagen secretion detection. The collected culture medium samples were centrifuged to remove cells and impurities. A specific collagen ELISA kit was used to quantitatively analyze the collagen concentration in the culture medium through a standard curve. The culture medium samples were subjected to protein concentration treatment and SDS-PAGE electrophoresis. The proteins were transferred to a PVDF membrane and incubated with a specific primary antibody for collagen and an HRP-labeled secondary antibody. A chemiluminescent substrate was used for color development. The expression of collagen was observed and recorded. The test results were statistically analyzed to calculate the synthesis and secretion of collagen.

[0021] In a preferred embodiment, the extraction and purification of collagen also includes centrifuging the cells and culture medium samples collected from the culture medium to remove cell residues, adding dilute hydrochloric acid to the supernatant, stirring overnight at 4°C to dissolve the collagen, neutralizing the acidic solution with sodium hydroxide, and then freeze-drying or dialysis to concentrate the collagen solution, ultracentrifuging the extracted collagen solution to remove fine impurities, dialysis using a molecular weight cutoff membrane to remove small molecule impurities and salts, selecting an appropriate ion exchange chromatography column, loading the collagen solution onto a balanced ion exchange chromatography column, eluting with a gradient salt solution, and collecting the collagen components in the eluate.

[0022] In a preferred embodiment, the quality inspection also includes taking an appropriate amount of purified collagen, drying it into a film or mixing it with KBr to make a tablet, scanning it using a Fourier transform infrared spectrometer to obtain an infrared spectrum, analyzing characteristic absorption peaks, confirming the secondary structure of the collagen, hydrolyzing the collagen sample with 6M HCl at 110°C for 24 hours to generate single amino acids, drying the hydrolyzate, and redissolving it in an appropriate diluent, loading the hydrolyzed sample onto an amino acid analysis column, using HPLC to separate and detect each amino acid, determining the content of each amino acid in the sample by comparison with a standard, confirming the consistency of its amino acid sequence with that of natural collagen, inoculating fibroblasts and bone marrow mesenchymal stem cells on a culture plate coated with collagen, observing and counting the number of adhered cells under a microscope, evaluating the cell adhesion ability of collagen, and confirming the biological activity of collagen through cell adhesion, proliferation and differentiation experiments to ensure its effectiveness in practical applications.

[0023] In a preferred embodiment, the cell identification and quality control also includes extracting total RNA from iPSCs, using TRIzol reagent or RNA extraction kit, reverse transcribing the extracted RNA into cDNA with reverse transcriptase, using specific primers, using SYBR Green or TaqMan probes for qPCR detection, quantitatively analyzing the expression level of pluripotency genes, culturing iPSCs to an appropriate density, treating with colchicine for 1-2 hours to arrest the cell division metaphase, treating the cells with a hypotonic solution to swell them, and then fixing them with methanol-glacial acetic acid, dropping the fixed cells on a slide, performing Giemsa staining, preparing chromosome pieces, observing the chromosome morphology under a microscope, analyzing whether the karyotype is normal, extracting genomic DNA from iPSCs, using a DNA extraction kit, using a sequencing library construction kit to prepare a sequencing library, using high-throughput sequencing technology to perform whole genome sequencing, and analyzing the data to detect chromosome abnormalities and gene mutations.

[0024] The technical effects achieved by the present invention are:

[0025] iPSCs can differentiate into almost all types of cells, including fibroblasts, which provide a rich source of cells for collagen synthesis. Through directed differentiation, the generation and function of fibroblasts can be precisely controlled in vitro, making them more efficient in synthesizing collagen. Using the donor's own cells for reprogramming and differentiation avoids the risk of immune rejection, which makes personalized medicine possible and can provide each patient with a tailored collagen synthesis program.

[0026] Unlike embryonic stem cells, iPSCs do not involve the use of embryos, which reduces ethical disputes. They use somatic cell reprogramming, which does not destroy embryos and meets ethical requirements. By optimizing culture conditions and gene regulation technology, the collagen synthesis efficiency of fibroblasts can be significantly improved to obtain high-quality and high-yield collagen. iPSCs technology allows strict quality control. Through karyotype analysis, whole genome sequencing and pluripotency marker detection, it ensures that iPSCs and differentiated cells have good genetic stability and pluripotency. Cell identification and quality control steps ensure that the cells used meet experimental and production requirements.

[0027] After collagen synthesis, comprehensive functional tests can be performed, including evaluation of cell proliferation, migration and collagen fiber formation ability. These tests ensure that the synthesized collagen has good biological activity and mechanical properties to meet the needs of practical applications. Through a variety of extraction and purification techniques, collagen can be efficiently separated and purified to ensure the purity and quality of the final product. Quality testing methods ensure that the structure and composition of collagen meet natural standards. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 It is a schematic diagram of a collagen biosynthesis method based on induced pluripotent stem cell technology of the present invention. DETAILED DESCRIPTION

[0029] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are described in detail below in conjunction with the accompanying drawings.

[0030] See also Figure 1 As shown, the present invention provides a method for collagen biosynthesis based on induced pluripotent stem cell technology, including the following steps:

[0031] Step 1. Cell reprogramming: Somatic cells, including fibroblasts and blood cells, are extracted from the donor's skin or blood. Reprogramming factors are introduced into somatic cells using viral vectors or non-viral methods. The viral vectors are retroviruses or adeno-associated viruses. Reprogramming factors include Oct4, Sox2, Klf4, and c-Myc. Under appropriate culture medium and conditions, somatic cells are reprogrammed into iPSCs, and iPSCs form characteristic cell colonies.

[0032] Step 2. iPSCs culture and expansion: Use a specific culture medium containing KOSR and bFGF to maintain the growth and pluripotency of iPSCs, use feeder-free culture medium or use culture plates coated with extracellular matrix proteins to regularly subculture iPSCs;

[0033] Step 3. Cell identification and quality control: Use immunofluorescence, flow cytometry or qPCR to detect the pluripotency markers of iPSCs, confirm the genetic stability of iPSCs through karyotype analysis and whole genome sequencing, and evaluate the pluripotency of iPSCs through in vitro differentiation experiments or in vivo tumor formation experiments;

[0034] Step 4. Directed differentiation: Use specific differentiation medium and growth factors to induce iPSCs to differentiate into fibroblasts or other collagen-synthesizing cell types. Optimize differentiation conditions by adjusting medium composition, cell density, culture temperature, and oxygen concentration. Use immunofluorescence and qPCR to detect fibroblast differentiation markers.

[0035] Step 5. Collagen synthesis and secretion: adjust the culture medium composition, amino acids, vitamin C, oxygen concentration and mechanical stress, regulate the expression of genes related to collagen synthesis through gene editing technology or small molecule compounds, collect culture medium samples regularly, and use ELISA or Western Blot to detect collagen secretion;

[0036] Step 6. Functional testing and optimization: Evaluate the biological functions of differentiated fibroblasts, including cell proliferation, migration, and collagen fiber formation ability. Use CRISPR / Cas9 technology to perform targeted editing of genes related to collagen synthesis. Use tensile tests and shear tests to evaluate the mechanical properties of synthesized collagen fibers.

[0037] Step 7. Extraction and purification of collagen: Collect secreted collagen from the culture medium, extract collagen by acid dissolution, salting out or enzymatic hydrolysis, purify collagen by centrifugation, dialysis, gel filtration chromatography, ion exchange chromatography, remove impurities, and detect the purity and molecular weight of purified collagen by SDS-PAGE, electrophoresis, and mass spectrometry;

[0038] Step 8. Quality inspection: Use infrared spectroscopy and circular dichroism to analyze the secondary structure of collagen, determine the amino acid composition of collagen, confirm the consistency of its amino acid sequence with natural collagen, and evaluate the effect of collagen on cell adhesion, proliferation and differentiation through cell culture experiments.

[0039] Cell reprogramming also includes using trypsin or collagenase to digest skin samples to separate fibroblasts, or using density gradient centrifugation to separate monocytes from blood samples, inoculating the separated cells in a culture dish, culturing them with a culture medium containing growth factors, and reprogramming the cells after they proliferate to a suitable density. Reprogramming factors include Oct4, Sox2, Klf4, and c-Myc. Co-incubating the reprogramming factor vector with somatic cells using methods including viral infection, plasmid electroporation, or liposome transfection, inoculating the somatic cells introduced with the reprogramming factors in a culture dish containing a feeder layer, and using KOSR culture medium for initial culture.

[0040] iPSCs culture and expansion also includes using feeder-free culture medium, coating the culture plate with extracellular matrix proteins to provide a surface suitable for iPSCs attachment and growth, diluting the matrix proteins before use and evenly coating the surface of the culture plate, incubating at room temperature for 30 minutes, inoculating the iPSCs suspension onto the pretreated feeder-free culture plate, culturing with feeder-free culture medium, using Dispase and Accutase enzymes to gently digest the cell colonies to disperse them into single cell suspensions or small colonies, transferring the digested cells to fresh culture medium by centrifugation and resuspension, Inoculate the cell suspension onto a new feeder-free culture plate at an appropriate dilution ratio, replace the culture medium regularly, remove waste and metabolites, add fresh nutrients, control the temperature, humidity and CO2 concentration of the culture environment to ensure that it is stable at 37°C, 95% relative humidity and 5% CO2, observe cell growth every day, record cell morphology and density, avoid excessive cell fusion or differentiation, regularly detect iPSCs pluripotency markers, Oct4, Sox2, and Nanog expression levels, regularly perform karyotype analysis and whole genome sequencing, and regularly detect microbial contamination in the culture medium.

[0041] Cell identification and quality control also include collecting iPSCs from culture dishes, fixing and permeabilizing the cells, fixing the cells with 4% paraformaldehyde solution for 10-15 minutes, then washing with PBS, treating with 0.1% Triton X-100 for 5-10 minutes at room temperature to permeabilize the cell membrane, blocking with 5% BSA or 10% normal goat serum for 1 hour at room temperature, diluting the primary antibody against pluripotency markers according to the recommended concentration, adding it to the blocked sample, incubating at 4°C overnight, washing with PBS, adding secondary antibodies with fluorescent labels, incubating at room temperature for 1 hour, protecting from light, observing the staining results with a fluorescence microscope, confirming the expression of pluripotency markers, digesting iPSCs into a single cell suspension, adjusting the cell concentration, mixing the cells with the fluorescently labeled primary antibody, incubating at 4°C for 30 minutes, washing the cells with PBS to remove unbound antibodies, and using a flow cytometer to detect the fluorescence intensity of pluripotency markers to analyze the pluripotency of the cells.

[0042] Directed differentiation also includes determining the target differentiation direction of iPSCs according to experimental requirements, selecting a basal culture medium suitable for the target cell type, adding specific growth factors and small molecules according to the target cell type, systematically adjusting the concentration and combination of each component in the culture medium, conducting gradient tests on the concentration of each growth factor and small molecule, and combining different growth factors and small molecules to find synergistic effects. During the differentiation process, timely subculture according to cell growth conditions, regularly collecting cell samples during the differentiation process for marker detection, fixing cells with 4% paraformaldehyde, permeabilizing them with 0.1% Triton X-100, incubating with primary and secondary antibodies using specific fibroblast marker antibodies, observing the expression of fibroblast markers, evaluating the differentiation effect, calculating the differentiation efficiency, evaluating the proportion of cells that have successfully differentiated under specific conditions, evaluating the functional properties of differentiated cells through collagen synthesis detection, migration and proliferation experiments, and culturing differentiated cells for a long time to observe their stability and functional retention.

[0043] Collagen synthesis and secretion also include simulating hypoxic conditions by adjusting the oxygen concentration of the incubator to promote collagen synthesis, simulating the mechanical stress that cells are subjected to in vivo, and promoting collagen synthesis and secretion of fibroblasts by applying mechanical stress using a bioreactor or a specially designed culture medium rack.

[0044] Functional testing and optimization also include using CRISPR / Cas9 technology to precisely regulate the expression of genes related to collagen synthesis, designing single guide RNA for target genes, and constructing CRISPR / Cas9 vectors, transfecting CRISPR / Cas9 vectors into fibroblasts, improving transfection efficiency by nucleic acid electroporation or liposome transfection, screening successfully edited cell lines, and using qPCR and Western blot. Blot was used to verify the expression of target genes, and small molecule compounds that can regulate the expression of genes related to collagen synthesis were screened. The synthesis and secretion of collagen were increased by adding these small molecule compounds. During the cell culture process, culture medium samples were collected regularly for collagen secretion detection. The collected culture medium samples were centrifuged to remove cells and impurities. A specific collagen ELISA kit was used to quantitatively analyze the collagen concentration in the culture medium through a standard curve. The culture medium samples were subjected to protein concentration treatment and SDS-PAGE electrophoresis. The proteins were transferred to a PVDF membrane and incubated with a specific primary antibody for collagen and an HRP-labeled secondary antibody. A chemiluminescent substrate was used for color development. The expression of collagen was observed and recorded. The test results were statistically analyzed to calculate the synthesis and secretion of collagen.

[0045] The extraction and purification of collagen also includes centrifuging the cells and culture medium samples collected from the culture medium to remove cell residues, adding dilute hydrochloric acid to the supernatant, stirring overnight at 4°C to dissolve the collagen, neutralizing the acidic solution with sodium hydroxide, and then freeze-drying or dialysis to concentrate the collagen solution, ultracentrifuging the extracted collagen solution to remove fine impurities, dialysis using a molecular weight cutoff membrane to remove small molecule impurities and salts, selecting an appropriate ion exchange chromatography column, loading the collagen solution onto a balanced ion exchange chromatography column, eluting with a gradient salt solution, and collecting the collagen components in the eluate.

[0046] Quality inspection also includes taking an appropriate amount of purified collagen, drying it into a film or mixing it with KBr to make a tablet, scanning it with a Fourier transform infrared spectrometer to obtain an infrared spectrum, analyzing characteristic absorption peaks, confirming the secondary structure of the collagen, hydrolyzing the collagen sample with 6M HCl at 110°C for 24 hours to produce single amino acids, drying the hydrolyzate, and redissolving it in an appropriate diluent, loading the hydrolyzed sample onto an amino acid analysis column, using HPLC to separate and detect each amino acid, determining the content of each amino acid in the sample by comparison with a standard, and confirming the consistency of its amino acid sequence with that of natural collagen, inoculating fibroblasts and bone marrow mesenchymal stem cells on a culture plate coated with collagen, observing and counting the number of adhered cells under a microscope, evaluating the cell adhesion ability of collagen, and confirming the biological activity of collagen through cell adhesion, proliferation and differentiation experiments to ensure its effectiveness in practical applications.

[0047] Cell identification and quality control also include extracting total RNA from iPSCs, using TRIzol reagent or RNA extraction kit, reverse transcribing the extracted RNA into cDNA with reverse transcriptase, calculating specific primers, using SYBR Green or TaqMan probes for qPCR detection, quantitatively analyzing the expression levels of pluripotency genes, culturing iPSCs to an appropriate density, treating with colchicine for 1-2 hours to arrest the cell division metaphase, treating the cells with a hypotonic solution to swell them, and then fixing them with methanol-glacial acetic acid, dropping the fixed cells on a slide, performing Giemsa staining, preparing chromosome pieces, observing the chromosome morphology under a microscope, analyzing whether the karyotype is normal, extracting genomic DNA from iPSCs, using a DNA extraction kit, using a sequencing library construction kit, preparing a sequencing library, performing whole genome sequencing using high-throughput sequencing technology, and analyzing the data to detect chromosomal abnormalities and gene mutations.

[0048] In the present invention, iPSCs can differentiate into almost all types of cells, including fibroblasts, which provide a rich source of cells for the synthesis of collagen. Through directed differentiation, the generation and function of fibroblasts can be precisely controlled in vitro, making them more efficient in synthesizing collagen. The use of the donor's own cells for reprogramming and differentiation avoids the risk of immune rejection, which makes personalized medicine possible and can provide each patient with a tailored collagen synthesis program.

[0049] Unlike embryonic stem cells, iPSCs do not involve the use of embryos, which reduces ethical disputes. They use somatic cell reprogramming, which does not destroy embryos and meets ethical requirements. By optimizing culture conditions and gene regulation technology, the collagen synthesis efficiency of fibroblasts can be significantly improved to obtain high-quality and high-yield collagen. iPSCs technology allows strict quality control. Through karyotype analysis, whole genome sequencing and pluripotency marker detection, it ensures that iPSCs and differentiated cells have good genetic stability and pluripotency. Cell identification and quality control steps ensure that the cells used meet experimental and production requirements.

[0050] After collagen synthesis, comprehensive functional tests can be performed, including evaluation of cell proliferation, migration and collagen fiber formation ability. These tests ensure that the synthesized collagen has good biological activity and mechanical properties to meet the needs of practical applications. Through a variety of extraction and purification techniques, collagen can be efficiently separated and purified to ensure the purity and quality of the final product. Quality testing methods ensure that the structure and composition of collagen meet natural standards.

[0051] The above is only a preferred embodiment of the present invention. It should be noted that, for those skilled in the art, several improvements and modifications can be made without departing from the principles of the present invention, and these improvements and modifications should also be considered as the protection scope of the present invention. The structures, devices and operating methods not specifically described and explained in the present invention shall be implemented according to the conventional means in the art unless otherwise specified and limited.

Claims

1. A method for collagen biosynthesis based on induced pluripotent stem cell technology, characterized in that: The collagen biosynthesis method specifically comprises the following steps: Step 1. Cell reprogramming: Somatic cells, including fibroblasts and blood cells, are extracted from the skin or blood of the donor, and reprogramming factors are introduced into the somatic cells using viral vectors or non-viral methods. The viral vectors are retroviruses or adeno-associated viruses, and the reprogramming factors include Oct4, Sox2, Klf4, and c-Myc. Under appropriate culture medium and conditions, the somatic cells are reprogrammed into iPSCs, and the iPSCs form characteristic cell colonies; Step 2. iPSCs culture and expansion: Use a specific culture medium containing KOSR and bFGF to maintain the growth and pluripotency of iPSCs, use feeder-free culture medium or use culture plates coated with extracellular matrix proteins to regularly subculture iPSCs; Step 3. Cell identification and quality control: Use immunofluorescence, flow cytometry or qPCR to detect the pluripotency markers of iPSCs, confirm the genetic stability of iPSCs through karyotype analysis and whole genome sequencing, and evaluate the pluripotency of iPSCs through in vitro differentiation experiments or in vivo tumor formation experiments; Step 4. Directed differentiation: Use specific differentiation medium and growth factors to induce iPSCs to differentiate into fibroblasts or other collagen-synthesizing cell types. Optimize differentiation conditions by adjusting medium composition, cell density, culture temperature, and oxygen concentration. Use immunofluorescence and qPCR to detect fibroblast differentiation markers. Step 5. Collagen synthesis and secretion: adjust the culture medium composition, amino acids, vitamin C, oxygen concentration and mechanical stress, regulate the expression of genes related to collagen synthesis through gene editing technology or small molecule compounds, collect culture medium samples regularly, and use ELISA or Western Blot to detect collagen secretion; Step 6. Functional testing and optimization: Evaluate the biological functions of differentiated fibroblasts, including cell proliferation, migration, and collagen fiber formation ability. Use CRISPR / Cas9 technology to perform targeted editing of genes related to collagen synthesis. Use tensile tests and shear tests to evaluate the mechanical properties of synthesized collagen fibers. Step 7. Extraction and purification of collagen: Collect secreted collagen from the culture medium, extract collagen by acid dissolution, salting out or enzymatic hydrolysis, purify collagen by centrifugation, dialysis, gel filtration chromatography, ion exchange chromatography, remove impurities, and detect the purity and molecular weight of purified collagen by SDS-PAGE, electrophoresis, and mass spectrometry; Step 8. Quality inspection: Use infrared spectroscopy and circular dichroism to analyze the secondary structure of collagen, determine the amino acid composition of collagen, confirm the consistency of its amino acid sequence with natural collagen, and evaluate the effect of collagen on cell adhesion, proliferation and differentiation through cell culture experiments.

2. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The cell reprogramming also includes using trypsin or collagenase to digest skin samples to separate fibroblasts, or using density gradient centrifugation to separate monocytes from blood samples, inoculating the separated cells in a culture dish, culturing them with a culture medium containing growth factors, and reprogramming the cells after they proliferate to a suitable density. The reprogramming factors include Oct4, Sox2, Klf4 and c-Myc, co-incubating the reprogramming factor vector with the somatic cells, and the method includes viral infection, plasmid electroporation or liposome transfection. The somatic cells introduced with the reprogramming factors are inoculated in a culture dish containing a feeder layer, and the KOSR culture medium is used for initial culture.

3. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The iPSCs culture and expansion also includes using a feeder-free culture medium, coating a culture plate with extracellular matrix proteins to provide a surface suitable for iPSCs to attach and grow, diluting the matrix proteins before use and evenly coating the culture plate surface, incubating at room temperature for 30 minutes, inoculating the iPSCs suspension onto the pre-treated feeder-free culture plate, culturing using a feeder-free culture medium, gently digesting the cell colonies using Dispase enzymes and Accutase enzymes to disperse them into single cell suspensions or small colonies, transferring the digested cells to fresh culture medium by centrifugation and resuspension. , inoculate the cell suspension onto a new feeder-free culture plate according to the appropriate dilution ratio, replace the culture medium regularly, remove waste and metabolites, add fresh nutrients, control the temperature, humidity and CO2 concentration of the culture environment to ensure that it is stable at 37°C, 95% relative humidity and 5% CO2, observe cell growth every day, record cell morphology and density, avoid excessive cell fusion or differentiation, regularly detect iPSCs pluripotency markers, Oct4, Sox2, Nanog expression levels, regularly perform karyotype analysis and whole genome sequencing, and regularly detect microbial contamination in the culture medium.

4. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The cell identification and quality control also includes collecting iPSCs from a culture dish, fixing and permeabilizing the cells, fixing the cells with a 4% paraformaldehyde solution for 10-15 minutes, then washing with PBS, treating with 0.1% Triton X-100 at room temperature for 5-10 minutes to permeabilize the cell membrane, blocking with 5% BSA or 10% normal goat serum at room temperature for 1 hour, diluting the primary antibody against pluripotency markers according to the recommended concentration, adding it to the blocked sample, incubating at 4°C overnight, washing with PBS, adding a secondary antibody with a fluorescent label, incubating at room temperature for 1 hour, protecting from light, observing the staining results with a fluorescence microscope, confirming the expression of pluripotency markers, digesting iPSCs into a single cell suspension, adjusting the cell concentration, mixing the cells with the fluorescently labeled primary antibody, incubating at 4°C for 30 minutes, washing the cells with PBS to remove unbound antibodies, using a flow cytometer to detect the fluorescence intensity of the pluripotency marker, and analyzing the pluripotency of the cells.

5. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The directed differentiation also includes determining the target differentiation direction of iPSCs according to experimental requirements, selecting a basal culture medium suitable for the target cell type, adding specific growth factors and small molecules according to the target cell type, systematically adjusting the concentration and combination of each component in the culture medium, performing gradient tests on the concentration of each growth factor and small molecule, and performing combination experiments of different growth factors and small molecules to find synergistic effects. During the differentiation process, timely subculturing according to cell growth conditions, regularly collecting cell samples during the differentiation process for marker detection, fixing cells with 4% paraformaldehyde, permeabilizing with 0.1% Triton X-100, incubating with primary and secondary antibodies using specific fibroblast marker antibodies, observing the expression of fibroblast markers, evaluating the differentiation effect, calculating the differentiation efficiency, evaluating the proportion of cells that have successfully differentiated under specific conditions, evaluating the functional characteristics of differentiated cells through collagen synthesis detection, migration and proliferation experiments, and culturing differentiated cells for a long time to observe their stability and functional retention.

6. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The collagen synthesis and secretion also includes simulating hypoxic conditions by adjusting the oxygen concentration of the incubator to promote collagen synthesis, simulating the mechanical stress to which cells are subjected in vivo, and promoting collagen synthesis and secretion of fibroblasts by applying mechanical stress using a bioreactor or a specially designed culture medium rack.

7. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The functional testing and optimization also includes using CRISPR / Cas9 technology to precisely regulate the expression of genes related to collagen synthesis, designing single guide RNA for target genes, and constructing CRISPR / Cas9 vectors, transfecting CRISPR / Cas9 vectors into fibroblasts, improving transfection efficiency by nucleic acid electroporation or liposome transfection, screening successfully edited cell lines, and using qPCR and Western blot. Blot was used to verify the expression of target genes, and small molecule compounds that can regulate the expression of genes related to collagen synthesis were screened. The synthesis and secretion of collagen were increased by adding these small molecule compounds. During the cell culture process, culture medium samples were collected regularly for collagen secretion detection. The collected culture medium samples were centrifuged to remove cells and impurities. A specific collagen ELISA kit was used to quantitatively analyze the collagen concentration in the culture medium through a standard curve. The culture medium samples were subjected to protein concentration treatment and SDS-PAGE electrophoresis. The proteins were transferred to a PVDF membrane and incubated with a specific primary antibody for collagen and an HRP-labeled secondary antibody. A chemiluminescent substrate was used for color development. The expression of collagen was observed and recorded. The test results were statistically analyzed to calculate the synthesis and secretion of collagen.

8. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The extraction and purification of collagen also includes centrifuging the cells and culture medium samples collected from the culture medium to remove cell residues, adding dilute hydrochloric acid to the supernatant, stirring overnight at 4°C to dissolve the collagen, neutralizing the acidic solution with sodium hydroxide, and then freeze-drying or dialysis to concentrate the collagen solution, ultracentrifuging the extracted collagen solution to remove fine impurities, dialysis using a molecular weight cutoff membrane to remove small molecule impurities and salt, selecting an appropriate ion exchange chromatography column, loading the collagen solution onto a balanced ion exchange chromatography column, eluting with a gradient salt solution, and collecting the collagen components in the eluate.

9. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The quality inspection also includes taking an appropriate amount of purified collagen, drying it into a film or mixing it with KBr to make a pressed tablet, scanning it with a Fourier transform infrared spectrometer to obtain an infrared spectrum, analyzing characteristic absorption peaks, confirming the secondary structure of the collagen, hydrolyzing the collagen sample with 6M HCl at 110°C for 24 hours to generate single amino acids, drying the hydrolyzate, redissolving it in an appropriate diluent, loading the hydrolyzed sample onto an amino acid analysis column, using HPLC to separate and detect each amino acid, determining the content of each amino acid in the sample by comparison with a standard, confirming the consistency of its amino acid sequence with that of natural collagen, inoculating fibroblasts and bone marrow mesenchymal stem cells on a culture plate coated with collagen, observing and counting the number of adhered cells under a microscope, evaluating the cell adhesion ability of collagen, and confirming the biological activity of collagen through cell adhesion, proliferation and differentiation experiments to ensure its effectiveness in practical applications.

10. The method for collagen biosynthesis based on induced pluripotent stem cell technology according to claim 1, characterized in that: The cell identification and quality control also includes extracting total RNA from iPSCs, using TRIzol reagent or RNA extraction kit, reverse transcribing the extracted RNA into cDNA with reverse transcriptase, calculating specific primers, using SYBR Green or TaqMan probe to perform qPCR detection, quantitatively analyzing the expression level of pluripotency genes, culturing iPSCs to an appropriate density, treating with colchicine for 1-2 hours to arrest the cell division metaphase, treating the cells with a hypotonic solution to swell them, and then fixing them with methanol-glacial acetic acid, dropping the fixed cells on a slide, performing Giemsa staining, preparing chromosome pieces, observing the chromosome morphology under a microscope, analyzing whether the karyotype is normal, extracting genomic DNA from iPSCs, using a DNA extraction kit, using a sequencing library construction kit to prepare a sequencing library, using high-throughput sequencing technology to perform whole genome sequencing, and analyzing the data to detect chromosome abnormalities and gene mutations.

Citation Information

Cited By

  • Cytological detection method of recombinant three-type humanized collagen

    CN119470309A

  • A cytological detection method for recombinant humanized type III collagen

    CN119470309B